Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
Vannucchi, Alessandro M, Kiladjian, Jean Jacques, Griesshammer, Martin, Masszi, Tamas, Durrant, Simon, Passamonti, Francesco, Harrison, Claire N, Pane, Fabrizio, Zachee, Pierre, Mesa, Ruben, He, Shui, Jones, Mark M, Garrett, William, Li, Jingjin, Pirron, Ulrich, Habr, Dany, Verstovsek, Srdan
Published in The New England journal of medicine (29.01.2015)
Published in The New England journal of medicine (29.01.2015)
Get full text
Journal Article
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Palumbo, Antonio, Chanan-Khan, Asher, Weisel, Katja, Nooka, Ajay K, Masszi, Tamas, Beksac, Meral, Spicka, Ivan, Hungria, Vania, Munder, Markus, Mateos, Maria V, Mark, Tomer M, Qi, Ming, Schecter, Jordan, Amin, Himal, Qin, Xiang, Deraedt, William, Ahmadi, Tahamtan, Spencer, Andrew, Sonneveld, Pieter
Published in The New England journal of medicine (25.08.2016)
Published in The New England journal of medicine (25.08.2016)
Get full text
Journal Article
Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study
O'Connor, Owen A, Horwitz, Steven, Masszi, Tamás, Van Hoof, Achiel, Brown, Peter, Doorduijn, Jeannette, Hess, Georg, Jurczak, Wojciech, Knoblauch, Poul, Chawla, Shanta, Bhat, Gajanan, Choi, Mi Rim, Walewski, Jan, Savage, Kerry, Foss, Francine, Allen, Lee F, Shustov, Andrei
Published in Journal of clinical oncology (10.08.2015)
Published in Journal of clinical oncology (10.08.2015)
Get full text
Journal Article
Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse
Moskowitz, Craig H., Walewski, Jan, Nademanee, Auayporn, Masszi, Tamas, Agura, Edward, Holowiecki, Jerzy, Abidi, Muneer H., Chen, Andy I., Stiff, Patrick, Viviani, Simonetta, Bachanova, Veronika, Sureda, Anna, McClendon, Teresa, Lee, Connie, Lisano, Julie, Sweetenham, John
Published in Blood (20.12.2018)
Published in Blood (20.12.2018)
Get full text
Journal Article
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
Moskowitz, Craig H, Dr Prof, Nademanee, Auayporn, Prof, Masszi, Tamas, Prof, Agura, Edward, Prof, Holowiecki, Jerzy, Prof, Abidi, Muneer H, Prof, Chen, Andy I, Prof, Stiff, Patrick, Prof, Gianni, Alessandro M, Prof, Carella, Angelo, Prof, Osmanov, Dzhelil, Prof, Bachanova, Veronika, Prof, Sweetenham, John, Prof, Sureda, Anna, Prof, Huebner, Dirk, MD, Sievers, Eric L, MD, Chi, Andy, PhD, Larsen, Emily K, MS, Hunder, Naomi N, MD, Walewski, Jan, Prof
Published in The Lancet (British edition) (09.05.2015)
Published in The Lancet (British edition) (09.05.2015)
Get full text
Journal Article
Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR
Spencer, Andrew, Lentzsch, Suzanne, Weisel, Katja, Avet-Loiseau, Hervé, Mark, Tomer M, Spicka, Ivan, Masszi, Tamas, Lauri, Birgitta, Levin, Mark-David, Bosi, Alberto, Hungria, Vania, Cavo, Michele, Lee, Je-Jung, Nooka, Ajay K, Quach, Hang, Lee, Cindy, Barreto, Wolney, Corradini, Paolo, Min, Chang-Ki, Scott, Emma C, Chanan-Khan, Asher A, Horvath, Noemi, Capra, Marcelo, Beksac, Meral, Ovilla, Roberto, Jo, Jae-Cheol, Shin, Ho-Jin, Sonneveld, Pieter, Soong, David, Casneuf, Tineke, Chiu, Christopher, Amin, Himal, Qi, Ming, Thiyagarajah, Piruntha, Sasser, A Kate, Schecter, Jordan M, Mateos, Maria-Victoria
Published in Haematologica (Roma) (01.12.2018)
Published in Haematologica (Roma) (01.12.2018)
Get full text
Journal Article
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
O'Connor, Owen A, Özcan, Muhit, Jacobsen, Eric D, Roncero, Josep M, Trotman, Judith, Demeter, Judit, Masszi, Tamás, Pereira, Juliana, Ramchandren, Radhakrishnan, Beaven, Anne, Caballero, Dolores, Horwitz, Steven M, Lennard, Anne, Turgut, Mehmet, Hamerschlak, Nelson, d'Amore, Francesco A, Foss, Francine, Kim, Won-Seog, Leonard, John P, Zinzani, Pier Luigi, Chiattone, Carlos S, Hsi, Eric D, Trümper, Lorenz, Liu, Hua, Sheldon-Waniga, Emily, Ullmann, Claudio Dansky, Venkatakrishnan, Karthik, Leonard, E Jane, Shustov, Andrei R
Published in Journal of clinical oncology (10.03.2019)
Published in Journal of clinical oncology (10.03.2019)
Get full text
Journal Article
Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients
Avet-Loiseau, Hervé, Bahlis, Nizar J., Chng, Wee-Joo, Masszi, Tamas, Viterbo, Luisa, Pour, Ludek, Ganly, Peter, Palumbo, Antonio, Cavo, Michele, Langer, Christian, Pluta, Andrzej, Nagler, Arnon, Kumar, Shaji, Ben-Yehuda, Dina, Rajkumar, S. Vincent, San-Miguel, Jesus, Berg, Deborah, Lin, Jianchang, van de Velde, Helgi, Esseltine, Dixie-Lee, di Bacco, Alessandra, Moreau, Philippe, Richardson, Paul G.
Published in Blood (14.12.2017)
Published in Blood (14.12.2017)
Get full text
Journal Article
Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma
Stewart, A Keith, Dimopoulos, Meletios A, Masszi, Tamás, Špička, Ivan, Oriol, Albert, Hájek, Roman, Rosiñol, Laura, Siegel, David S, Niesvizky, Ruben, Jakubowiak, Andrzej J, San-Miguel, Jesus F, Ludwig, Heinz, Buchanan, Jacqui, Cocks, Kim, Yang, Xinqun, Xing, Biao, Zojwalla, Naseem, Tonda, Margaret, Moreau, Philippe, Palumbo, Antonio
Published in Journal of clinical oncology (10.11.2016)
Published in Journal of clinical oncology (10.11.2016)
Get full text
Journal Article
Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial
Verstovsek, Srdan, Vannucchi, Alessandro M, Griesshammer, Martin, Masszi, Tamas, Durrant, Simon, Passamonti, Francesco, Harrison, Claire N, Pane, Fabrizio, Zachee, Pierre, Kirito, Keita, Besses, Carlos, Hino, Masayuki, Moiraghi, Beatriz, Miller, Carole B, Cazzola, Mario, Rosti, Vittorio, Blau, Igor, Mesa, Ruben, Jones, Mark M, Zhen, Huiling, Li, Jingjin, Francillard, Nathalie, Habr, Dany, Kiladjian, Jean-Jacques
Published in Haematologica (Roma) (01.07.2016)
Published in Haematologica (Roma) (01.07.2016)
Get full text
Journal Article
Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study
Kiladjian, Jean-Jacques, Zachee, Pierre, Hino, Masayuki, Pane, Fabrizio, Masszi, Tamas, Harrison, Claire N, Mesa, Ruben, Miller, Carole B, Passamonti, Francesco, Durrant, Simon, Griesshammer, Martin, Kirito, Keita, Besses, Carlos, Moiraghi, Beatriz, Rumi, Elisa, Rosti, Vittorio, Blau, Igor Wolfgang, Francillard, Nathalie, Dong, Tuochuan, Wroclawska, Monika, Vannucchi, Alessandro M, Verstovsek, Srdan
Published in The Lancet. Haematology (01.03.2020)
Published in The Lancet. Haematology (01.03.2020)
Get more information
Journal Article
Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients
Lovas, Szilvia, Varga, Gergely, Farkas, Péter, Masszi, Tamás, Wohner, Nikolett, Bereczki, Ágnes, Adamkovich, Nóra, Borbényi, Zita, Szomor, Árpád, Alizadeh, Hussain, Szaleczky, Erika, Wolf, Krisztina, Schneider, Tamás, Plander, Márk, Szendrei, Tamás, Csacsovszki, Ottó, Csukly, Zoltán, Rajnics, Péter, Egyed, Miklós, Nagy, Zsolt, Rejtő, László, Illés, Árpád, Mikala, Gábor, Váróczy, László
Published in International journal of hematology (01.11.2019)
Published in International journal of hematology (01.11.2019)
Get full text
Journal Article
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial
Kantarjian, Hagop, Pasquini, Ricardo, Hamerschlak, Nelson, Rousselot, Philippe, Holowiecki, Jerzy, Jootar, Saengsuree, Robak, Tadeusz, Khoroshko, Nina, Masszi, Tamas, Skotnicki, Aleksander, Hellmann, Andrzej, Zaritsky, Andrey, Golenkov, Anatoly, Radich, Jerald, Hughes, Timothy, Countouriotis, Athena, Shah, Neil
Published in Blood (15.06.2007)
Published in Blood (15.06.2007)
Get full text
Journal Article
Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study
Schjesvold, Fredrik H, Ludwig, Heinz, Delimpasi, Sossana, Robak, Pawel, Coriu, Daniel, Tomczak, Waldemar, Pour, Ludek, Spicka, Ivan, Dimopoulos, Meletios-Athanasios, Masszi, Tamas, Chernova, Natalia G, Sandberg, Anna, Thuresson, Marcus, Norin, Stefan, Bakker, Nicolaas A, Mateos, Maria-Victoria, Richardson, Paul G, Sonneveld, Pieter
Published in Haematologica (Roma) (01.07.2024)
Published in Haematologica (Roma) (01.07.2024)
Get full text
Journal Article
Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs . placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1
Mateos, María-Victoria, Masszi, Tamas, Grzasko, Norbert, Hansson, Markus, Sandhu, Irwindeep, Pour, Ludek, Viterbo, Luísa, Jackson, Sharon R, Stoppa, Anne-Marie, Gimsing, Peter, Hamadani, Mehdi, Borsaru, Gabriela, Berg, Deborah, Lin, Jianchang, Di Bacco, Alessandra, van de Velde, Helgi, Richardson, Paul G, Moreau, Philippe
Published in Haematologica (Roma) (01.10.2017)
Published in Haematologica (Roma) (01.10.2017)
Get full text
Journal Article
Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations
Andrikovics, Hajnalka, Krahling, Tunde, Balassa, Katalin, Halm, Gabriella, Bors, Andras, Koszarska, Magdalena, Batai, Arpad, Dolgos, Janos, Csomor, Judit, Egyed, Miklos, Sipos, Andrea, Remenyi, Peter, Tordai, Attila, Masszi, Tamas
Published in Haematologica (Roma) (01.07.2014)
Published in Haematologica (Roma) (01.07.2014)
Get full text
Journal Article
Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia
Trask, Peter C, Cella, David, Besson, Nadine, Kelly, Virginia, Masszi, Tamás, Kim, Dong-Wook
Published in Leukemia research (01.04.2012)
Published in Leukemia research (01.04.2012)
Get full text
Journal Article
Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning
Tordai, Attila, Bors, Andras, Kiss, Katalin Piroska, Balassa, Katalin, Andrikovics, Hajnalka, Batai, Arpad, Szilvasi, Aniko, Rajczy, Katalin, Inotai, Dora, Torbagyi, Eva, Lengyel, Lilla, Barta, Aniko, Remenyi, Peter, Masszi, Tamas
Published in PloS one (25.06.2019)
Published in PloS one (25.06.2019)
Get full text
Journal Article
Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients
Nádasdi, Ákos, Sinkovits, György, Bobek, Ilona, Lakatos, Botond, Förhécz, Zsolt, Prohászka, Zita Z, Réti, Marienn, Arató, Miklós, Cseh, Gellért, Masszi, Tamás, Merkely, Béla, Ferdinandy, Péter, Vályi-Nagy, István, Prohászka, Zoltán, Firneisz, Gábor
Published in Biomarkers in medicine (01.04.2022)
Published in Biomarkers in medicine (01.04.2022)
Get full text
Journal Article
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up
Gambacorti‐Passerini, Carlo, Brümmendorf, Tim H., Kim, Dong‐Wook, Turkina, Anna G., Masszi, Tamas, Assouline, Sarit, Durrant, Simon, Kantarjian, Hagop M., Khoury, H. Jean, Zaritskey, Andrey, Shen, Zhi‐Xiang, Jin, Jie, Vellenga, Edo, Pasquini, Ricardo, Mathews, Vikram, Cervantes, Francisco, Besson, Nadine, Turnbull, Kathleen, Leip, Eric, Kelly, Virginia, Cortes, Jorge E.
Published in American journal of hematology (01.07.2014)
Published in American journal of hematology (01.07.2014)
Get full text
Journal Article